EFPIA - NEWSLETTER

EFPIA Newsletter 31 October 2019

Blogs

31 October 2019 #WeWontRest until we beat Alzheimer’s disease

Unlocking the mystery behind Alzheimer's disease and dementia and improving care for people require new types of partnership....

30 October 2019 Is gene therapy the beginning of a revolution in medicine?

Ever since the Human Genome Project started unravelling the mysteries of our genes in the 1990s, a lot of hope has been...

29 October 2019 No one can win the fight against disease on their own

We can no longer afford to have a narrow focus when the solutions that patients require call for a broad coalition of...

24 October 2019 The economy of well-being

EFPIA welcomes the Council Conclusions on the Economy of Wellbeing, aiming to put people and their wellbeing at the...

Videos

LIF interview with Nathalie Moll

Anders Blanck, General Director at LIF, interviews Nathalie Moll, General Director at EFPIA, about what the Nordic countries and the EU can do to combat AMR, how the Swedish Life Science industry can become more competitive and how patients can get access to cell and gene therapy.

#WeWontRest until we make rare disease even rarer

Rare diseases are far more common than you might think, but treatments are rare. #WeWontRest until no one is left behind and no one will need to tackle rare diseases alone.

Events

19 NOV 2019

Clinical Trials Europe 2019 Barcelona, Spain

Hundreds of leading clinical trials industry professionals will be gathering in Barcelona at the 17th annual Clinical...

Learn more →

19 NOV 2019

Data Protection in Health Research Brussels

A dialogue among policymakers, authorities, manufacturers of medicinal products and medical technologies, and other...

Learn more →

21 NOV 2019

Improving health outcomes for people with diabetes: The role of data, access to innovation... European Parliament

The role of data, access to innovation and integrated care

Learn more →

15 JAN 2020

Save the Date | Joint EFGCP-EFPIA multi-stakeholder discussion Crowne Plaza Le Palace, Brussels

Roadmap Initiative to Good Lay Summary Practices

Learn more →

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶